Open access · OA
via OpenAlex
Low Production Capacity of Interleukin-10 Associates With the Metabolic Syndrome and Type 2 Diabetes
Eric R. van Exel, Jacobijn Gussekloo, Anton J.M. de Craen, Marijke Frölich, Annetje Bootsma‐van Der Wiel, Rudi G. J. Westendorp
Diabetes · 2002 · ▲ 358 citations
Abstract
It has been suggested that the metabolic syndrome and type 2 diabetes are manifestations of the inflammatory host response. This host response is orchestrated by the production of pro- and anti-inflammatory cytokines that are under genetic control. We therefore hypothesized that a low production capacity of interleukin-10 (IL-10), a centrally operating cytokine with strong anti-inflammatory properties, associates with the metabolic syndrome and type 2 diabetes in old age. In the current study, 599 inhabitants of the city of Leiden, age 85 years, were visited at their place of residence. The production capacity of the anti-inflammatory cytokine IL-10 was assessed in a whole-blood assay in which lipopolysaccharide was used as a stimulus. Serum concentrations of lipids, lipoproteins, glucose, and HbA(1c) were determined, and a history of type 2 diabetes was obtained. Serum concentrations of total cholesterol, LDL cholesterol, triglycerides, glucose, and HbA(1c) gradually decreased over strata representing higher IL-10 production capacity, whereas the concentration of HDL cholesterol gradually increased (all P < 0.01). The odds ratio for type 2 diabetes was 2.7 (95% confidence interval 1.5-4.9) when subjects with the lowest IL-10 production capacity were compared with those with the highest IL-10 production capacity. These findings showed that low IL-10 production capacity (i.e., a pro-inflammatory response) is associated with the metabolic syndrome and type 2 diabetes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2337/diabetes.51.4.1088
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Exel, E.R.V., Gussekloo, J., Craen, A.J.D., Frölich, M., Wiel, A.B.D., & Westendorp, R.G.J. (2002). Low Production Capacity of Interleukin-10 Associates With the Metabolic Syndrome and Type 2 Diabetes. <em>Diabetes</em>. https://doi.org/10.2337/diabetes.51.4.1088
Vancouver
Exel ERV, Gussekloo J, Craen AJD, Frölich M, Wiel ABD, Westendorp RGJ. Low Production Capacity of Interleukin-10 Associates With the Metabolic Syndrome and Type 2 Diabetes. Diabetes. 2002. doi:10.2337/diabetes.51.4.1088.
BibTeX
@article{eric2002LowPro,
title = {Low Production Capacity of Interleukin-10 Associates With the Metabolic Syndrome and Type 2 Diabetes},
author = {Eric R. van Exel and Jacobijn Gussekloo and Anton J.M. de Craen and Marijke Frölich and Annetje Bootsma‐van Der Wiel and Rudi G. J. Westendorp},
journal = {Diabetes},
year = {2002},
doi = {10.2337/diabetes.51.4.1088},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Diabetes Research and Clinical Practice 2007
Preprint · CC-BY
Renal manifestations of metabolic syndrome in type 2 diabetes
Obesity Facts 2012
Citation only
The Impact of Type 2 Diabetes on Circulating Adipokines in Patients with Metabolic Syndrome
Acta Diabetologica 2009
Citation only
Metabolic syndrome is independently associated with microalbuminuria in type 2 diabetes
Diabetes Research and Clinical Practice 2005
Citation only
Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis
Diabetes Research and Clinical Practice 2007
Citation only
Stroke presentation in Type 2 diabetes and the metabolic syndrome
International Journal of Applied Exercise Physiology 2017
Open access · CC-BY